According to the relevant laws and regulations, marketing authorization holders are obliged to carry out the post-marketing surveillance of drugs. This page will collect information related to your unsolicited feedback to the extent permitted.
If the information you provide relates to a adverse event involving Akeso’s products, the relevant patient information and data will be disclosed to Akeso’s pharmacovigilance department in accordance with the applicable laws and regulations, and the relevant personnel may follow up with you on the safety event. The information will be input into Akeso’s pharmacovigilance database and reported to the relevant regulatory departments in accordance with the applicable laws and regulations. Items marked with * are required. Please fill in the information accurately.
Note: The information marked with * is a required option, please fill in accurately.
*Choose your identity: